145 related articles for article (PubMed ID: 19782074)
21. Comparative Effectiveness of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in Older Nursing Home Residents After Myocardial Infarction: A Retrospective Cohort Study.
Zullo AR; Riester MR; Erqou S; Wu WC; Rudolph JL; Steinman MA
Drugs Aging; 2020 Oct; 37(10):755-766. PubMed ID: 32808250
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II Blood Levels Are Associated with Smaller Hippocampal and Cortical Volumes in Cognitively Normal Older Adults.
Yasar S; Moored KD; Adam A; Zabel F; Chuang YF; Varma VR; Carlson MC
J Alzheimers Dis; 2020; 75(2):521-529. PubMed ID: 32280103
[TBL] [Abstract][Full Text] [Related]
23. Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives.
Wharton W; Zhao L; Steenland K; Goldstein FC; Schneider JA; Barnes LL; Gearing M; Yasar S
J Alzheimers Dis; 2019; 70(1):153-161. PubMed ID: 31177216
[TBL] [Abstract][Full Text] [Related]
24. Alteration in Brain Functional and Effective Connectivity in Subjects With Hypertension.
Bu L; Huo C; Xu G; Liu Y; Li Z; Fan Y; Li J
Front Physiol; 2018; 9():669. PubMed ID: 29904355
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.
Forrester SJ; Booz GW; Sigmund CD; Coffman TM; Kawai T; Rizzo V; Scalia R; Eguchi S
Physiol Rev; 2018 Jul; 98(3):1627-1738. PubMed ID: 29873596
[TBL] [Abstract][Full Text] [Related]
26. Cognitive benefits of angiotensin IV and angiotensin-(1-7): A systematic review of experimental studies.
Ho JK; Nation DA
Neurosci Biobehav Rev; 2018 Sep; 92():209-225. PubMed ID: 29733881
[TBL] [Abstract][Full Text] [Related]
27. Associations of Angiotensin Converting Enzyme-1 and Angiotensin II Blood Levels and Cognitive Function.
Yasar S; Varma VR; Harris GC; Carlson MC
J Alzheimers Dis; 2018; 63(2):655-664. PubMed ID: 29660936
[TBL] [Abstract][Full Text] [Related]
28. Moringa oleifera supplemented diet modulates nootropic-related biomolecules in the brain of STZ-induced diabetic rats treated with acarbose.
Oboh G; Oyeleye SI; Akintemi OA; Olasehinde TA
Metab Brain Dis; 2018 Apr; 33(2):457-466. PubMed ID: 29435808
[TBL] [Abstract][Full Text] [Related]
29. Captopril and Valsartan May Improve Cognitive Function Through Potentiation of the Brain Antioxidant Defense System and Attenuation of Oxidative/Nitrosative Damage in STZ-Induced Dementia in Rat.
Arjmand Abbassi Y; Mohammadi MT; Sarami Foroshani M; Raouf Sarshoori J
Adv Pharm Bull; 2016 Dec; 6(4):531-539. PubMed ID: 28101460
[No Abstract] [Full Text] [Related]
30. Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies.
Peters R; Schuchman M; Peters J; Carlson MC; Yasar S
Curr Hypertens Rep; 2016 Aug; 18(8):66. PubMed ID: 27492369
[TBL] [Abstract][Full Text] [Related]
31. Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1.
Papadopoulos P; Tong XK; Imboden H; Hamel E
J Cereb Blood Flow Metab; 2017 Jun; 37(6):1959-1970. PubMed ID: 27389178
[TBL] [Abstract][Full Text] [Related]
32. Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.
Hamel E; Royea J; Ongali B; Tong XK
Cell Mol Neurobiol; 2016 Mar; 36(2):219-32. PubMed ID: 26993506
[TBL] [Abstract][Full Text] [Related]
33. Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention.
Nation DA; Ho J; Yew B;
J Alzheimers Dis; 2016; 50(3):779-89. PubMed ID: 26757036
[TBL] [Abstract][Full Text] [Related]
34. Targeting AGEs Signaling Ameliorates Central Nervous System Diabetic Complications in Rats.
Zakaria MN; El-Bassossy HM; Barakat W
Adv Pharmacol Sci; 2015; 2015():346259. PubMed ID: 26491434
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer's Disease.
Jiang T; Zhang YD; Zhou JS; Zhu XC; Tian YY; Zhao HD; Lu H; Gao Q; Tan L; Yu JT
Mol Neurobiol; 2016 May; 53(4):2489-97. PubMed ID: 26044748
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues.
Obulesu M; Lakshmi MJ
Neurochem Res; 2014 Dec; 39(12):2301-12. PubMed ID: 25322820
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink.
Goh KL; Bhaskaran K; Minassian C; Evans SJ; Smeeth L; Douglas IJ
Br J Clin Pharmacol; 2015 Feb; 79(2):337-50. PubMed ID: 25223602
[TBL] [Abstract][Full Text] [Related]
38. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system.
Benoist CC; Kawas LH; Zhu M; Tyson KA; Stillmaker L; Appleyard SM; Wright JW; Wayman GA; Harding JW
J Pharmacol Exp Ther; 2014 Nov; 351(2):390-402. PubMed ID: 25187433
[TBL] [Abstract][Full Text] [Related]
39. Association of gene variants of the renin-angiotensin system with accelerated hippocampal volume loss and cognitive decline in old age.
Zannas AS; McQuoid DR; Payne ME; MacFall JR; Ashley-Koch A; Steffens DC; Potter GG; Taylor WD
Am J Psychiatry; 2014 Nov; 171(11):1214-21. PubMed ID: 25124854
[TBL] [Abstract][Full Text] [Related]
40. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.
Wright JW; Kawas LH; Harding JW
Front Endocrinol (Lausanne); 2013 Oct; 4():158. PubMed ID: 24298267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
